Retraction notice to "Therapeutic prospects of modulating TLR4/MAPK/ROS signalling in obesity-associated neuroinflammation" [Biomedicine & Pharmacotherapy 193 (2025) 118805] - 21/05/26
Doi : 10.1016/j.biopha.2026.119420
Drashti Sharma a, Ram Narayanan Ravi b, ⁎, Amar Daud Iskandar Abdullah a, Vetriselvan Subramaniyan a, c, d, e, ⁎
a Department of Biomedical Sciences, Sir Jeffrey Cheah Sunway Medical School, Faculty of Medical and Life Sciences, Sunway University, Malaysia
b Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Selangor Darul Ehsan, Malaysia
c School of Allied and Public Health Sciences, Malla Reddy Vishwavidyapeeth, Hederabad, India
d Global Research Cell, Dr. D. Y. Patil Dental College & Hospital, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, India
e Department of Pharmacy, Faculty of Pharmacy, Karpagam Academy of Higher Education (Deemed to be University), Coimbatore, India
⁎ Corresponding authors.
Le texte complet de cet article est disponible en PDF.
© 2026
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 199
Article 119420- juin 2026 Retour au numéro
Article précédent
- Retraction notice to "The black Vitis vinifera seed oil saponifiable fraction ameliorates hepatocellular carcinoma in vitro and in vivo via modulating apoptosis and ROS/NF-κB signaling" [Biomedicine & Pharmacotherapy 171 (2024) 116215]
- Nadia Z. Shaban, Ashraf A. El-Faham, Marwa M. Abu-Serie, Noha H. Habashy
- Retraction notice to "Jiedu Tongluo Baoshen formula enhances renal tubular epithelial cell autophagy to prevent renal fibrosis by activating SIRT1/LKB1/AMPK pathway" [Biomedicine & Pharmacotherapy 160 (2023) 114340]
- Di Jin, Yunyun Zhao, Yuting Sun, Jiaojiao Xue, Xiangyan Li, Xiuge Wang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?